Trump and Republican candidates made rolling back federal protections for transgender people a big issue, spending hundreds of millions of dollars on TV ads, much of it focused on gender-affirming care for minors. Despite the attention, a new study finds that gender-affirming medications are very rarely prescribed to adolescents. John Yang speaks with KFF’s Lindsey Dawson to learn more.